Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avanos Medical (AVNS) Cost of Revenue (2016 - 2024)

Historic Cost of Revenue for Avanos Medical (AVNS) over the last 12 years, with Q3 2024 value amounting to $77.5 million.

  • Avanos Medical's Cost of Revenue rose 224.27% to $77.5 million in Q3 2024 from the same period last year, while for Sep 2024 it was $303.2 million, marking a year-over-year increase of 312.93%. This contributed to the annual value of $293.6 million for FY2023, which is 127.63% up from last year.
  • Avanos Medical's Cost of Revenue amounted to $77.5 million in Q3 2024, which was up 224.27% from $76.1 million recorded in Q2 2024.
  • In the past 5 years, Avanos Medical's Cost of Revenue registered a high of $100.0 million during Q2 2021, and its lowest value of $3.5 million during Q4 2021.
  • For the 5-year period, Avanos Medical's Cost of Revenue averaged around $76.9 million, with its median value being $77.5 million (2024).
  • In the last 5 years, Avanos Medical's Cost of Revenue tumbled by 9644.67% in 2021 and then soared by 214857.14% in 2022.
  • Avanos Medical's Cost of Revenue (Quarter) stood at $98.5 million in 2020, then crashed by 96.45% to $3.5 million in 2021, then surged by 2148.57% to $78.7 million in 2022, then dropped by 0.51% to $78.3 million in 2023, then fell by 1.02% to $77.5 million in 2024.
  • Its last three reported values are $77.5 million in Q3 2024, $76.1 million for Q2 2024, and $71.3 million during Q1 2024.